Skip to main content
NutriBand Inc. logo

NutriBand Inc. — Investor Relations & Filings

Ticker · NTRB ISIN · US67092M2089 LEI · 549300OZV3WLQQWOD724 US Manufacturing
Filings indexed 254 across all filing types
Latest filing 2022-01-03 Regulatory Filings
Country US United States of America
Listing US NTRB

About NutriBand Inc.

https://nutriband.com/

NutriBand Inc. is a biopharmaceutical company focused on the development of transdermal pharmaceutical products. The company's core activity involves creating advanced drug delivery platforms to enhance patient safety and outcomes. Its primary technology is AVERSA™, a patented abuse-deterrent system designed for transdermal patches. This technology aims to prevent the misuse and abuse of potent medications, particularly opioids, by releasing aversive agents if tampering occurs. NutriBand's lead product under development is an abuse-deterrent transdermal system for fentanyl. The company is engaged in research, development, and manufacturing scale-up of its innovative drug delivery solutions.

Recent filings

Filing Released Lang Actions
CURRENT REPORT
Regulatory Filings
2022-01-03 English
424B3
Regulatory Filings
2022-01-03 English
CURRENT REPORT
Regulatory Filings
2021-12-30 English
QUARTERLY REPORT
Interim / Quarterly Report Q3 2022
2021-12-14 English
DEFINITIVE PROXY STATEMENT
Proxy Solicitation & Information Statement
2021-12-09 English
PROSPECTUS SUPPLEMENT
Regulatory Filings
2021-11-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.